Girard Partners’s Opko Health OPK Stock Holding History

Girard Partners’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,200	Closed	-$11K	–	630
2018 Q3	$11K	Buy	+3,200	New	+$17K	﹤0.01%	724

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Girard Partners's OPK Position: Q4 2018 in Review

Girard Partners sold out of Opko Health (OPK) in Q4 2018, closing a stake of 3,200 shares — an estimated $11K sold.

Girard Partners first reported a position in OPK in Q3 2018 and held it in 1 quarter. The position peaked at $11K in Q3 2018. 202 funds tracked by Wall St. Rank hold OPK as of Q4 2018.

Girard Partners reported no remaining Opko Health position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 3,200 Opko Health shares in Q4 2018, an estimated $11K.
Girard Partners first reported a position in Opko Health in Q3 2018 and held it in 1 quarter.
Girard Partners's Opko Health position peaked at $11K in Q3 2018.
202 funds tracked by Wall St. Rank held Opko Health as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.